Cathie Wood’s ARK Invest made a series of portfolio moves on Thursday, July 9, 2026. The biggest trade of the day was a $20.55 million purchase of Meta Platforms stock through the ARK Innovation ETF.
ARK bought 34,080 shares of Meta. The move came just weeks before Meta is set to report its second-quarter earnings on July 29.
Wall Street expects Meta to post earnings per share of $7.17 on revenue of $60.19 billion for the quarter.
The purchase followed a string of AI-related announcements from Meta. The company launched Muse Spark 1.1, its first paid AI model, and unveiled new AI tools for businesses.
Meta also said its in-house AI chip, Iris, is set for mass production in September. The company announced plans to invest more than $13 billion in a new data center in Alberta, Canada.
On TipRanks, Meta holds a Strong Buy consensus rating based on 34 Buy ratings and five Hold ratings. The average price target of $817.15 points to roughly 29.4% upside from current levels. Meta shares are down 4.2% year-to-date.
On the sell side, ARK offloaded 10,774 shares of Advanced Micro Devices through its ARKK ETF. The sale was worth $5.57 million. This is part of a broader pullback in AMD, with ARK reducing its position over the past week.
ARK also sold 85,319 shares of Robinhood Markets for $9.69 million and 70,154 shares of Roku for $9.77 million.
Shares of Twist Bioscience were also trimmed, with ARK selling 98,776 shares for $8.83 million.
Beyond Meta, ARK added to its position in Circle Internet Group. It bought 217,896 shares across its ARKK, ARKW, and ARKF ETFs, totaling $13.96 million.
ARK also picked up 105,364 shares of Ionis Pharmaceuticals for $8.9 million and 544,385 shares of Prime Medicine for $2.52 million.
Smaller buys included 57,462 shares of Generate Biomedicines for $911,921 and 46,302 shares of Compass Pathways for $646,838.
Meta stock rose 6.58% on July 10, the day after ARK’s purchase was disclosed.
The post Cathie Wood Just Spent $20M on Meta — Here’s Why She’s Selling AMD appeared first on CoinCentral.